New Delhi, Jan 27 (PTI) Glenmark Pharmaceuticals Ltd on Thursday said its US subsidiary has received final approval from the country's health regulator for its generic Bisoprolol Fumarate and Hydrochlorothiazide tablets used to treat high blood pressure.

The approval granted to Glenmark Pharmaceuticals Inc, USA by the United States Food & Drug Administration (USFDA) is for Bisoprolol Fumarate and Hydrochlorothiazide tablets of strengths 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 MG, the company said in a statement.

Also Read | Google Hits Back at Deceptive Android Location Tracking Lawsuit in the US.

These are generic versions of Ziac tablets, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg, of Teva Branded Pharmaceutical Products R&D, Inc, it added.

Citing IQVIATM sales data for the 12 months ending November 2021, the company said these Ziac tablets had annual sales of approximately USD 30.3 million.

Also Read | MPSC Group C Recruitment 2022: Last Date Extended till Jan 31; Apply For 900 Posts on mpsc.gov.in; Check Details Here.

Glenmark said its current portfolio consists of 172 products authorised for distribution in the US marketplace and 46 abbreviated new drug applications pending approval with the USFDA.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)